{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:23:38Z","timestamp":1791411818998,"version":"4.3.3"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":4177,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.ymthe.2005.01.011","type":"journal-article","created":{"date-parts":[[2005,2,15]],"date-time":"2005-02-15T17:08:56Z","timestamp":1108487336000},"page":"754-762","source":"Crossref","is-referenced-by-count":84,"title":["AAV Vector-Mediated Correction of Brain Pathology in a Mouse Model of Niemann\u2013Pick A Disease"],"prefix":"10.1016","volume":"11","author":[{"given":"Marco A.","family":"Passini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon L.","family":"Macauley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Huff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana V.","family":"Taksir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Huan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Piepenhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Dodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamya S.","family":"Shihabuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine R.","family":"O'Riordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward H.","family":"Schuchman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory R.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2005.01.011_bib1","series-title":"The Metabolic and Molecular Basis of Inherited Disease","first-page":"3589","article-title":"Niemann\u2013Pick disease types A and B: acid sphingomyelinase deficiencies","author":"Schuchman","year":"2001"},{"key":"10.1016\/j.ymthe.2005.01.011_bib2","doi-asserted-by":"crossref","first-page":"44976","DOI":"10.1074\/jbc.M106455200","article-title":"Acid sphingomyelinase deficient macrophages have defective cholesterol trafficking and efflux","volume":"276","author":"Leventhal","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2005.01.011_bib3","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency\u2014macrophage-targeted glucocerebrosidase for Gaucher's disease","volume":"324","author":"Barton","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2005.01.011_bib4","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1182\/blood.V78.5.1183.1183","article-title":"Enzyme replacement therapy for Gaucher disease","volume":"78","author":"Beutler","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2005.01.011_bib5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1089\/10430340252837198","article-title":"Critical issues in gene therapy for neurologic disease","volume":"13","author":"Hsich","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2005.01.011_bib6","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0733-8619(02)00010-5","article-title":"Gene therapy for the central nervous system in the lysosomal storage disorders","volume":"20","author":"Kaye","year":"2002","journal-title":"Neurol. Clin. North Am."},{"key":"10.1016\/j.ymthe.2005.01.011_bib7","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1096\/fj.00-0014com","article-title":"Infusion of recombinant human acid sphingomyelinase into Niemann\u2013Pick disease mice leads to visceral, but not neurological, correction of the pathophysiology","volume":"14","author":"Miranda","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2005.01.011_bib8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrn1104","article-title":"Viral vectors for gene delivery to the nervous system","volume":"4","author":"Davidson","year":"2003","journal-title":"Nat. Neurosci. Rev."},{"key":"10.1016\/j.ymthe.2005.01.011_bib9","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1089\/hum.1998.9.8-1181","article-title":"Selective and rapid uptake of adeno-associated virus type 2 in brain","volume":"9","author":"Bartlett","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2005.01.011_bib10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng1094-148","article-title":"Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain","volume":"8","author":"Kaplitt","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2005.01.011_bib11","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1523\/JNEUROSCI.22-15-06437.2002","article-title":"Distribution of a lysosomal enzyme in the adult brain by axonal transport and by cells of the rostral migratory stream","volume":"22","author":"Passini","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymthe.2005.01.011_bib12","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/ng0795-288","article-title":"Acid sphingomyelinase deficient mice: a model of types A and B Niemann\u2013Pick disease","volume":"10","author":"Horinouchi","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2005.01.011_bib13","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1172\/JCI14862","article-title":"Intracerebral transplantation of mesenchymal stem cells into acid sphingomyelinase-deficient mice delays the onset of neurological abnormalities and extends their life span","volume":"109","author":"Jin","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2005.01.011_bib14","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0092-8674(05)80010-8","article-title":"Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann\u2013Pick disease)","volume":"81","author":"Otterbach","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2005.01.011_bib15","series-title":"The Rat Nervous System","first-page":"443","article-title":"Hippocampal formation","author":"Amaral","year":"1995"},{"key":"10.1016\/j.ymthe.2005.01.011_bib16","series-title":"The Rat Nervous System","first-page":"405","article-title":"Septum","author":"Jakab","year":"1995"},{"key":"10.1016\/j.ymthe.2005.01.011_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.0953-816x.2001.01564.x","article-title":"Patterned cerebellar Purkinje cell death in a transgenic mouse model of Niemann Pick type A\/B disease","volume":"13","author":"Sarna","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ymthe.2005.01.011_bib18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"20","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ymthe.2005.01.011_bib19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.bi.60.070191.001353","article-title":"Lysosomal storage diseases","volume":"60","author":"Neufeld","year":"1991","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ymthe.2005.01.011_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1750-3639.1998.tb00144.x","article-title":"Cellular pathology of lysosomal storage disorders","volume":"8","author":"Walkley","year":"1998","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ymthe.2005.01.011_bib21","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1073\/pnas.082011999","article-title":"Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors","volume":"30","author":"Brooks","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2005.01.011_bib22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1006\/mthe.2001.0274","article-title":"Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII","volume":"3","author":"Frisella","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2005.01.011_bib23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/BF00219337","article-title":"Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease","volume":"88","author":"Leinekugel","year":"1992","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymthe.2005.01.011_bib24","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1038\/sj.gt.3301300","article-title":"Hematopoietic stem cell gene therapy leads to marked visceral organ improvements and a delayed onset of neurological abnormalities in the acid sphingomyelinase deficient mouse model of Niemann\u2013Pick disease","volume":"7","author":"Miranda","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2005.01.011_bib25","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng0693-154","article-title":"Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts","volume":"4","author":"Moullier","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2005.01.011_bib26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1126\/science.169.3941.141","article-title":"Inborn errors of mucopolysaccharide metabolism","volume":"169","author":"Neufeld","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2005.01.011_bib27","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1172\/JCI1773","article-title":"Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function","volume":"101","author":"O'Connor","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2005.01.011_bib28","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1006\/exnr.2000.7531","article-title":"Somatic gene therapy for a neurodegenerative disease using microencapsulated recombinant cells","volume":"166","author":"Ross","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymthe.2005.01.011_bib29","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0092-8674(77)90262-8","article-title":"Recognition and receptor-mediated uptake of a lysosomal enzyme, alpha-l-iduronidase, by cultured human fibroblasts","volume":"12","author":"Sando","year":"1977","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2005.01.011_bib30","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nm0797-771","article-title":"Decreased lysosomal storage in the adult MPS VII mouse brain in the vicinity of grafts of retroviral vector-corrected fibroblasts secreting high levels of beta-glucuronidase","volume":"3","author":"Taylor","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2005.01.011_bib31","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/360749a0","article-title":"Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer","volume":"360","author":"Wolfe","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2005.01.011_bib32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-1-4615-5901-6_10","article-title":"Cholesterol\u2014sphingomyelin interactions in cells-effects on lipid metabolism","volume":"28","author":"Slotte","year":"1997","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.ymthe.2005.01.011_bib33","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/jmg.27.8.499","article-title":"Very low levels of high density lipoprotein cholesterol in four sibs of a family with non neuropathic Niemann\u2013Pick disease and sea-blue histiocytosis","volume":"27","author":"Viana","year":"1990","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymthe.2005.01.011_bib34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1227\/01.NEU.0000044459.24519.3E","article-title":"Intraneural colchicine inhibition of adenoviral and adeno-associated viral vector remote spinal cord gene delivery","volume":"52","author":"Boulis","year":"2003","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ymthe.2005.01.011_bib35","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/mthe.2001.0520","article-title":"Targeted retrograde gene delivery for neuronal protection","volume":"5","author":"Kaspar","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2005.01.011_bib36","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.1086137","article-title":"Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model","volume":"301","author":"Kaspar","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2005.01.011_bib37","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ymthe.2004.05.024","article-title":"Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system","volume":"10","author":"Burger","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2005.01.011_bib38","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S1525-0016(03)00066-2","article-title":"Adeno-associated virus-mediated aspartoacylase gene transfer to the brain of knockout mouse for Canavan disease","volume":"7","author":"Matalon","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2005.01.011_bib39","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1523\/JNEUROSCI.23-08-03302.2003","article-title":"Intravitreal gene therapy reduces lysosomal storage in specific areas of the CNS in mucopolysaccharidosis VII mice","volume":"23","author":"Hennig","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymthe.2005.01.011_bib40","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0006-8993(98)00169-3","article-title":"Recombinant adeno-associated virus vector: use for transgene expression and anterograde tract tracing in the CNS","volume":"793","author":"Chamberlin","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.ymthe.2005.01.011_bib41","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0065-3527(00)55015-5","article-title":"Adeno-associated virus vector mediated gene transfer to somatic cells in the central nervous system","volume":"55","author":"Klein","year":"2000","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.ymthe.2005.01.011_bib42","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.72.3.2224-2232.1998","article-title":"Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus","volume":"72","author":"Xiao","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2005.01.011_bib43","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/1521-2254(200011\/12)2:6<444::AID-JGM132>3.0.CO;2-1","article-title":"Scaleable chromatographic purification process for recombinant adeno-associated virus","volume":"2","author":"O'Riordan","year":"2000","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ymthe.2005.01.011_bib44","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1089\/10430349950018427","article-title":"Highly-purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses","volume":"10","author":"Clark","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2005.01.011_bib45","series-title":"Protocols for Gene Transfer in Neuroscience: Towards Gene Therapy of Neurological Disorders","first-page":"263","article-title":"Murine mucopolysaccharidosis type VII: a model for somatic gene therapy of the central nervous system","author":"Wolfe","year":"1996"},{"key":"10.1016\/j.ymthe.2005.01.011_bib46","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1128\/JVI.77.12.7034-7040.2003","article-title":"Intraventricular brain injection of adeno-associated virus type 1 in neonatal mice results in complementary patterns of neuronal transduction to AAV2 and total long-term correction of storage lesions in the brains of \u03b2-glucuronidase-deficient mice","volume":"77","author":"Passini","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2005.01.011_bib47","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0076-6879(00)16751-5","article-title":"In situ hybridization studies of retinal neurons","volume":"316","author":"Barthel","year":"2000","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ymthe.2005.01.011_bib48","doi-asserted-by":"crossref","first-page":"12382","DOI":"10.1128\/JVI.75.24.12382-12392.2001","article-title":"Widespread gene delivery and structure specific patterns of expression in the brain after intraventricular injections of neonatal mice with an adeno associated virus vector","volume":"75","author":"Passini","year":"2001","journal-title":"J. Virol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001605000195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001605000195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T19:49:09Z","timestamp":1586116149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001605000195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S1525001605000195"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2005.01.011","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}